Company Filing History:
Years Active: 2008-2013
Title: Matthias Kotzsch: Innovator in Cancer Diagnostics
Introduction
Matthias Kotzsch is a prominent inventor based in Dresden, Germany. He has made significant contributions to the field of cancer diagnostics through his innovative research and patented inventions. With a total of 2 patents, his work focuses on the detection and prognosis of breast tumors and related medical applications.
Latest Patents
One of Matthias Kotzsch's latest patents is titled "Nucleic acids encoding a deletion variant of uPAR." This invention pertains to the production of specific antibodies for the detection of human tumor-associated urokinase-type plasminogen activator receptor (uPAR) deletion variants in biological samples. It also addresses their diagnostic and therapeutic applications. Another notable patent is "Methods for the detection and prognosis of breast tumors," which similarly relates to the production of specific antibodies for detecting uPAR deletion variants in biological samples.
Career Highlights
Matthias Kotzsch is associated with Wilex AG, a company known for its focus on developing innovative cancer therapies. His work at Wilex AG has positioned him as a key player in advancing cancer diagnostics and treatment options.
Collaborations
Matthias has collaborated with notable colleagues such as Thomas Luther and Viktor Magdolen. Their combined expertise has contributed to the success of their research and innovations in the field.
Conclusion
Matthias Kotzsch's contributions to cancer diagnostics through his patents and collaborations highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in cancer detection and treatment.